Tiny 'Test Drive' implant could help find best drugs for pancreatic cancer
NCT ID NCT07254091
Summary
This early study is testing the safety of a tiny, implantable device in patients with pancreatic cancer who are already scheduled for surgery. The device, placed and removed during the operation, releases tiny amounts of different chemotherapy drugs into the tumor tissue to see how the cancer cells react. The main goal is to see if using this device is safe and to learn if it can help doctors understand which drugs might work best for an individual's cancer before starting full treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zuckerberg Cancer Center
RECRUITINGNew Hyde Park, New York, 11040, United States
Conditions
Explore the condition pages connected to this study.